Eileen M. O’Reilly - Researcher Profile

Publications

2 shown

Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

Talia Golan , Pascal Hammel , Michele Reni +16 more

Among patients with a germline <i>BRCA</i> mutation and metastatic pancreatic cancer, progression-free survival was longer with maintenance olaparib than with placebo. (Funded b...

2019 New England Journal of Medicine 2076 citations

Pancreatic Cancer

Wungki Park , Akhil Chawla , Eileen M. O’Reilly

Approximately 60 000 new cases of PDAC are diagnosed per year, and approximately 50% of patients have advanced disease at diagnosis. The incidence of PDAC is increasing. Current...

2021 JAMA 1568 citations